Corteva Reports Third Quarter and Year-to-Date 2024 Results, Updates Full-Year 2024 Guidance, Provides 2025 Preliminary Outlook
Corteva (NYSE: CTVA) reported Q3 2024 financial results showing declining performance. Net sales decreased 10% to $2.33B, with a net loss of $519M. Year-to-date net sales declined 4% to $12.93B with income of $913M. Seed sales showed price gains but volume declines due to reduced corn planted area in Latin America. Crop Protection sales decreased 9% due to weather and destocking impacts.
The company updated its 2024 guidance, expecting net sales of $17.0-17.2B and Operating EBITDA of $3.35-3.45B. For 2025, preliminary outlook projects net sales of $17.3-17.7B and Operating EBITDA of $3.6-4.0B.
Corteva (NYSE: CTVA) ha riportato risultati finanziari per il terzo trimestre del 2024 che mostrano un andamento in calo. Le vendite nette sono diminuite del 10% a $2,33 miliardi, con una perdita netta di $519 milioni. Da inizio anno, le vendite nette sono calate del 4% a $12,93 miliardi, con un reddito di $913 milioni. Le vendite di sementi hanno mostrato aumenti di prezzo ma diminuzioni del volume a causa della riduzione dell'area di mais coltivata in America Latina. Le vendite di protezione delle colture sono diminuite del 9% a causa degli impatti climatici e della riduzione delle scorte.
La società ha aggiornato il suo guidance 2024, prevedendo vendite nette di $17,0-17,2 miliardi e un EBITDA operativo di $3,35-3,45 miliardi. Per il 2025, la previsione preliminare stima vendite nette di $17,3-17,7 miliardi e un EBITDA operativo di $3,6-4,0 miliardi.
Corteva (NYSE: CTVA) reportó resultados financieros para el tercer trimestre de 2024 que muestran un desempeño en declive. Las ventas netas disminuyeron un 10% a $2.33 mil millones, con una pérdida neta de $519 millones. Hasta la fecha, las ventas netas han bajado un 4% a $12.93 mil millones con un ingreso de $913 millones. Las ventas de semillas mostraron aumentos de precios pero disminuciones en volumen debido a la reducción del área sembrada de maíz en América Latina. Las ventas de protección de cultivos cayeron un 9% debido a impactos climáticos y reducción de inventarios.
La compañía actualizó su guía 2024, esperando ventas netas de $17.0-17.2 mil millones y un EBITDA operativo de $3.35-3.45 mil millones. Para 2025, el pronóstico preliminar proyecta ventas netas de $17.3-17.7 mil millones y un EBITDA operativo de $3.6-4.0 mil millones.
Corteva (NYSE: CTVA)는 2024년 3분기 재무 결과를 발표하며 성과가 감소하고 있음을 보여주었습니다. 순매출은 10% 감소하여 23억 3천만 달러에 이르며, 순손실은 5억 1천9백만 달러였습니다. 연초부터 지금까지 순매출은 4% 감소하여 129억 3천만 달러에 달하고, 수익은 9억 1천3백만 달러입니다. 종자의 판매는 가격 상승을 보였지만 아메리카 대륙에서 옥수수 재배 면적이 줄어들어 물량이 감소했습니다. 작물 보호 판매는 기상 및 재고 축소의 영향으로 9% 감소했습니다.
회사는 2024년 가이던스를 업데이트하며 순매출이 170억~172억 달러, 운영 EBITDA는 33억 5천만~34억 5천만 달러를 예상하고 있습니다. 2025년의 예비 전망은 순매출이 173억~177억 달러, 운영 EBITDA는 36억~40억 달러로 예상하고 있습니다.
Corteva (NYSE: CTVA) a annoncé ses résultats financiers pour le troisième trimestre de 2024, montrant une performance en baisse. Les ventes nettes ont baissé de 10 % pour atteindre 2,33 milliards de dollars, avec une perte nette de 519 millions de dollars. Depuis le début de l'année, les ventes nettes ont chuté de 4 % à 12,93 milliards de dollars, avec un revenu de 913 millions de dollars. Les ventes de semences ont montré des augmentations de prix mais des baisses de volume en raison de la réduction de la superficie de maïs cultivée en Amérique latine. Les ventes de protection des cultures ont diminué de 9 % en raison des impacts météo et de la réduction des stocks.
L'entreprise a mis à jour sa prévision pour 2024, s'attendant à des ventes nettes de 17,0 à 17,2 milliards de dollars et un EBITDA opérationnel de 3,35 à 3,45 milliards de dollars. Pour 2025, les prévisions préliminaires projettent des ventes nettes de 17,3 à 17,7 milliards de dollars et un EBITDA opérationnel de 3,6 à 4,0 milliards de dollars.
Corteva (NYSE: CTVA) hat die finanziellen Ergebnisse für das dritte Quartal 2024 veröffentlicht, die eine rückläufige Leistung zeigen. Die Nettoumsätze sind um 10% auf 2,33 Milliarden US-Dollar gesunken, mit einem Nettverlust von 519 Millionen US-Dollar. Von Jahresbeginn an sind die Nettoumsätze um 4% auf 12,93 Milliarden US-Dollar gefallen, bei einem Einkommen von 913 Millionen US-Dollar. Die Umsätze mit Saatgut zeigten Preissteigerungen, jedoch Rückgänge im Volumen aufgrund einer reduzierten Maisanbaufläche in Lateinamerika. Die Umsätze im Pflanzenschutz verringerten sich um 9% aufgrund von Wetterbedingungen und Lagerabbauten.
Das Unternehmen hat seine Prognose für 2024 aktualisiert und erwartet Nettoumsätze von 17,0-17,2 Milliarden US-Dollar sowie ein operatives EBITDA von 3,35-3,45 Milliarden US-Dollar. Für 2025 wird in der vorläufigen Prognose von Nettoumsätzen von 17,3-17,7 Milliarden US-Dollar und einem operativen EBITDA von 3,6-4,0 Milliarden US-Dollar ausgegangen.
- 4% price increase in Seed segment led by North America
- Volume growth in Latin America for new products
- Projected $1B in share repurchases for 2024
- Expected Free Cash Flow of $1.5-2.0B for 2024
- Q3 net sales declined 10% to $2.33B
- Q3 net loss of $519M, 65% worse than previous year
- Crop Protection sales decreased 9%
- 5% price decline in Crop Protection due to Latin America market dynamics
- Reduced corn planted area in Latin America affecting volumes
Insights
Corteva's Q3 2024 results reveal significant challenges, with
Key concerns include Latin America's reduced corn planted area and challenging market dynamics in EMEA. While Seed pricing showed strength with a
The preliminary 2025 outlook targeting
- 3Q YTD performance reflects Seed price / mix gains and ongoing benefits from controllables
- 3Q results and Full Year 20243 impacted by
Latin America planted area and market dynamics - Preliminary 2025 outlook3 for strong Operating EBITDA1 growth and margin expansion
3Q 2024 Results Overview | |||
Net Sales |
Loss from Cont. Ops (After Tax) |
EPS | |
GAAP | |||
vs. 3Q 2023 | (10) % | (65) % | (69) % |
Organic1 Sales | Operating EBITDA1 | Operating EPS1 | |
NON-GAAP | |||
vs. 3Q 2023 | (5) % | n/m | (113) % |
2024 YTD Results Overview | |||
Net Sales |
Income from Cont. Ops (After Tax) |
EPS | |
GAAP | |||
vs. 2023 YTD | (4) % | (22) % | (21) % |
Organic1 Sales | Operating EBITDA1 | Operating EPS1 | |
NON-GAAP | |||
vs. 2023 YTD | (2) % | (5) % | (12) % |
2024 YTD Highlights
- Net sales declined
4% versus prior year. Organic1 sales decreased2% in the same period. - Seed net sales decreased
1% and organic1 sales increased1% . Price was up4% led byNorth America 2 with continued execution on the Company's price for value strategy. Volume declines reflect reduced corn planted area inLatin America , as well as unfavorable weather and reduced planted area in EMEA2. - Crop Protection net sales decreased
9% and organic1 sales decreased7% . Volume declines were driven by weather and destocking impacts in EMEA2, as well as just-in-time purchasing behavior inNorth America 2, partially offset by volume growth inLatin America on demand for new products and spinosyns. Price declined5% primarily due to the market dynamics inLatin America . - GAAP income and earnings per share (EPS) from continuing operations were
and$913 million per share, respectively.$1.29 - Operating EBITDA1 and Operating EPS1 were
, and$2.85 billion per share, respectively.$2.24 - The Company updated full-year 2024 guidance3 and expects net sales in the range of
to$17.0 . Operating EBITDA1 is expected to be$17.2 billion to$3.35 . Operating EPS1 is expected to be$3.45 billion to$2.50 per share. Cash provided by operating activities from continuing operations is expected to be$2.60 to$2.1 billion . Free Cash Flow1 is expected to be$2.6 billion to$1.5 billion . The Company expects it will have repurchased approximately$2.0 billion shares during 2024.$1 billion - The Company provided a preliminary outlook3 for 2025 and expects net sales in the range of
to$17.3 . Operating EBITDA1 is expected to be in the range of$17.7 billion to$3.6 .$4.0 billion
1. Organic Sales, Operating EPS, Operating EBITDA, and Free Cash Flow are non-GAAP measures. See page 7 for further discussion. 2. North America is defined as U.S. and Canada. EMEA is defined as Europe, Middle East and |
"Corteva's third quarter results were largely in line with expectations. We continued to execute effectively and are on track to deliver over
The Crop Protection business delivered earnings and margin growth in the quarter led by demand for our differentiated technology along with deflation benefits. Following a strong first half, the Seed business was impacted by lower planted area in
Despite greater market challenges in the second half of the year, we are still on track for margin expansion in 2024.
Today, we also provided a first look at 2025 with double digit earnings growth expected, driven by factors largely in our control. We remain committed to delivering advanced technology to our customers and generating consistent, incremental value to our shareholders."
Chuck Magro
Chief Executive Officer
Summary of Third Quarter 2024
For the third quarter ended September 30, 2024, net sales decreased
Volume was up
Price declined
GAAP income from continuing operations after income taxes was a loss of
3Q | 3Q | % | % | |
($ in millions, except where noted) | 2024 | 2023 | Change | Organic1 Change |
Net Sales | (10) % | (5) % | ||
North America | 7 % | 7 % | ||
EMEA | (12) % | (9) % | ||
Latin America | (19) % | (10) % | ||
Asia Pacific | (4) % | (2) % |
2024 |
2023 |
% |
% | |
($ in millions, except where noted) | YTD | YTD | Change | Organic1 Change |
Net Sales | (4) % | (2) % | ||
North America | - | - | ||
EMEA | (11) % | (5) % | ||
Latin America | (10) % | (7) % | ||
Asia Pacific | (4) % | (1) % |
Seed Summary
Seed net sales were
Price reflects higher end of season settlements in
Segment operating EBITDA was a loss of
3Q |
3Q |
% |
% | |
($ in millions, except where noted) | 2024 | 2023 | Change | Organic1 Change |
North America |
|
|
(2) % |
(2) % |
EMEA | (1) % | 3 % | ||
Latin America | (43) % | (36) % | ||
Asia Pacific | (16) % | (13) % | ||
Total 3Q Seed Net Sales |
|
|
(21) % |
(17) % |
3Q Seed Operating EBITDA |
|
|
(132) % |
N/A |
Seed net sales were
The increase in Seed price was driven by strong demand for top technology offerings and operational execution globally, with global corn and soybean prices up
Segment operating EBITDA was
2024 |
2023 |
% |
% | |
($ in millions, except where noted) | YTD | YTD | Change | Organic1 Change |
North America |
|
|
4 % |
4 % |
EMEA | (5) % | 5 % | ||
Latin America | (18) % | (17) % | ||
Asia Pacific | (11) % | (8) % | ||
Total YTD Seed Net Sales |
|
|
(1) % |
1 % |
YTD Seed Operating EBITDA |
|
|
8 % |
N/A |
Crop Protection Summary
Crop Protection net sales were approximately
The increase in volume was driven primarily by
Segment operating EBITDA was
3Q |
3Q |
% |
% | |
($ in millions, except where noted) | 2024 | 2023 | Change | Organic1 Change |
North America |
|
|
10 % |
10 % |
EMEA | (19) % | (18) % | ||
Latin America | (9) % | 2 % | ||
Asia Pacific | 4 % | 5 % | ||
Total 3Q Crop Protection Net Sales |
|
|
(4) % |
1 % |
3Q Crop Protection Operating EBITDA |
|
|
34 % |
N/A |
Crop Protection net sales were approximately
The decrease in volume was primarily due to residual destocking and unfavorable weather impacts in EMEA2, as well as just-in-time purchasing behavior in
The price decline was primarily due to market dynamics in Latin America. Unfavorable currency impacts were led by the Brazilian Real and the Turkish Lira. The portfolio impact was driven by the Biologicals acquisitions.
Segment operating EBITDA was
2024 |
2023 |
% |
% | |
($ in millions, except where noted) | YTD | YTD | Change | Organic1 Change |
North America |
|
|
(10) % |
(10) % |
EMEA | (16) % | (14) % | ||
Latin America | (5) % | (1) % | ||
Asia Pacific | (1) % | 2 % | ||
Total YTD Crop Protection Net Sales |
|
|
(9) % |
(7) % |
YTD Crop Protection Operating EBITDA |
|
|
(27) % |
N/A |
2024 Guidance and 2025 Preliminary Outlook
Commodity prices are relatively steady, despite an anticipated record
While the global Crop Protection industry volumes have continued to stabilize, the pricing environment remains competitive. Third quarter gains in Operating EBITDA1, including significant benefits from productivity and raw material deflation, reflect the resilience of our Crop Protection business.
As a result, for full-year 2024, Corteva now expects net sales in the range of
For full-year 2025, Corteva has a preliminary outlook3 of net sales in the range of
The Company is not able to reconcile its forward-looking non-GAAP financial measures, except for Free Cash Flow, to its most comparable
Third Quarter Conference Call
The Company will host a live webcast of its third quarter 2024 earnings conference call with investors to discuss its results and outlook tomorrow, November 7, 2024, at 9:00 a.m. ET. The slide presentation that accompanies the conference call is posted on the Company's Investor Events and Presentations page. A replay of the webcast will also be available on the Investor Events and Presentations page.
Corteva to Host Investor Day
The Company will host a live webcast of its Investor Day on November 19, 2024, at 9:00 a.m. ET. The Company's CEO, Chuck Magro, along with the Company's senior leadership team will provide updates on the company's strategy and position as an Ag technology company, sustainable growth platforms, business operational efficiency, innovation highlights and financial targets through 2027.
About Corteva
Corteva, Inc. (NYSE: CTVA) is a global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world's most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.
Cautionary Statement About Forward-Looking Statements
This report contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like "plans," "expects," "will," "anticipates," "believes," "intends," "projects," "estimates," "outlook," or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva's financial results or outlook; strategy for growth; product development; regulatory approvals; market position; capital allocation strategy; liquidity; environmental, sustainability targets and initiatives; the anticipated benefits of acquisitions, restructuring actions, or cost savings initiatives; and the outcome of contingencies, such as litigation and environmental matters, are forward-looking statements.
Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond Corteva's control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on Corteva's business, results of operations and financial condition. Some of the important factors that could cause Corteva's actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some of Corteva's products; (ii) failure to successfully develop and commercialize Corteva's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of Corteva's biotechnology and other agricultural products; (iv) effect of changes in agricultural and related policies of governments and international organizations; (v) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (vi) effect of climate change and unpredictable seasonal and weather factors; (vii) failure to comply with competition and antitrust laws; (viii) effect of competition in Corteva's industry; (ix) competitor's establishment of an intermediary platform for distribution of Corteva's products; (x) impact of Corteva's dependence on third parties with respect to certain of its raw materials or licenses and commercialization; (xi) effect of volatility in Corteva's input costs; (xii) risk related to geopolitical and military conflict; (xii) risks related to environmental litigation and the indemnification obligations of legacy EIDP liabilities in connection with the separation of Corteva; (xiv) risks related to Corteva's global operations; (xv) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xvi) effect of industrial espionage and other disruptions to Corteva's supply chain, information technology or network systems;(xvii) failure of Corteva's customers to pay their debts to Corteva, including customer financing programs; (xviii) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to Corteva; (xix) increases in pension and other post-employment benefit plan funding obligations; (xx) capital markets sentiment towards sustainability matters; (xxi) risks related to pandemics or epidemics; (xxii) Corteva's intellectual property rights or defense against intellectual property claims asserted by others; (xxiii) effect of counterfeit products; (xxiv) Corteva's dependence on intellectual property cross-license agreements; and (xxv) other risks related to the Separation from DowDuPont.
Additionally, there may be other risks and uncertainties that Corteva is unable to currently identify or that Corteva does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Corteva's management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the "Risk Factors" section of Corteva's Annual Report on Form 10-K, as modified by subsequent Quarterly Reports on Forms 10-Q and Current Reports on Form 8-K.
Regulation G (Non-GAAP Financial Measures)
This earnings release includes information that does not conform to
Corteva is not able to reconcile its forward-looking non-GAAP financial measures, except for Free Cash Flow, to its most comparable
Organic sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items. Operating EBITDA is defined as earnings (loss) (i.e., income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items. Non-operating benefits (costs) consists of non-operating pension and other post- employment benefit (OPEB) credits (costs), tax indemnification adjustments, and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the Company as pre-tax income or expense. Operating EBITDA margin is defined as Operating EBITDA as a percentage of net sales.
Operating earnings (loss) per share is defined as "earnings (loss) per common share from continuing operations - diluted" excluding the after-tax impact of significant items, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the Company's intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, amortization of intangibles (existing as of Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs.
The Company also uses Free Cash Flow as a non-GAAP measure to evaluate and discuss its liquidity position and ability to generate cash. Free Cash Flow is defined as cash provided by (used for) operating activities – continuing operations, less capital expenditures. Management believes that Free Cash Flow provides investors with meaningful information regarding the company's ongoing ability to generate cash through core operations, and the company's ability to service its indebtedness, pay dividends (when declared), make share repurchases, and meet its ongoing cash needs for its operations.
® TM Corteva Agriscience and its affiliated companies.
View original content to download multimedia:https://www.prnewswire.com/news-releases/corteva-reports-third-quarter-and-year-to-date-2024-results-updates-full-year-2024-guidance-provides-2025-preliminary-outlook-302297950.html
SOURCE Corteva, Inc.
FAQ
What was Corteva's (CTVA) Q3 2024 revenue?
What is Corteva's (CTVA) full-year 2024 revenue guidance?
What is Corteva's (CTVA) preliminary revenue outlook for 2025?